Browse our 1,000+ Publications​

Latest Publications

Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity

Mazzotti et al.
HLA
January 2026
Authors and Affiliates
Lucia Mazzotti, Patricia Borges de Souza, Irene Azzali, Davide Angeli, Oriana Nanni, Vittorio Sambri, Simona Semprini, Sara Bravaccini, Claudio Cerchione, Anna Gaimari, Fabio Nicolini, Valentina Ancarani, Giovanni Martinelli, Anna Pasetto, Hugo Calderon, Manel Juan, Massimiliano Mazza.

Patterns of restricted TCR usage following SARS-CoV-2 vaccination and severe disease

Parsons E et al.
Frontiers in Immunology
January 2026
Authors and Affiliates
Emily Parsons, Zhongyan Lu, Stephanie A. Richard, Amanda Zelkoski, Janifer Le, Naraen Palanikumar, Phuong Nguyen, Camille Alba, Gauthaman Sukumar, John Rosenberger, Xijun Zhang, Timothy H. Burgess, Rhonda Colombo, Katrin Mende, Catherine Berjohn, Nursat Epsi, Brian K. Agan, David Tribble, David A. Lindholm, Clifton L. Dalgard, Simon D. Pollett, Allison M. W. Malloy* and EPICC COVID-19 Cohort Study Group

T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis

Hesham ElAbd, et al.
Nature Medicine
June 2025
Authors and Affiliates
Hesham ElAbd, Mitchell Pesesky, Gabriel Innocenti, Brian K. Chung, Aya K. H. Mahdy, Valeriia Kriukova, Laila Kulsvehagen, Dennis Strobbe, Claudia Stühler, Gabriele Mayr, Damon H. May, Melanie Prinzensteiner, Tim A. Steiert, Florian Tran, Michel V. Hadjihannas, Rainer Günther, Elisa Rosati, Sören Mucha, Wolfgang Lieb, Malte Ziemann, Astrid Dempfle, Felix Braun, Trine Folseraas, Johannes R. Hov, Espen Melum, Petra Bacher, Martina Sterneck, Tobias J. Weismüller, Henrike Lenzen, Bernd Bokemeyer, Bryan Howie, Harlan S. Robins, Christoph Röcken, Stefan Schreiber, Nina Khanna, Anne-Katrin Pröbstel, Christoph Schramm, Thomas Vogl, Tom H. Karlsen & Andre Franke

SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMTCTN 2101)

Hill JA, et al.
January 2024
Authors and Affiliates
Joshua A. Hill, MD; Michael J. Martens, PhD; Jo-Anne H. Young, MD; Kavita Bhavsar, MSc; Jianqun Kou, MS; Min Chen, MS; Lik Wee Lee, PhD; Aliyah Baluch, MD; Madhav V. Dhodapkar, MBBS; Ryotaro Nakamura, MD; Kristin Peyton, BS; Dianna S. Howard, MD; Uroosa Ibrahim, MD; Zainab Shahid, MD; Paul Armistead, MD; Peter Westervelt, MD; John McCarty, MD; Joseph McGuirk, DO; Mehdi Hamadani, MD; Susan DeWolf, MD; Kinga Hosszu, PhD; Elad Sharon, MD, MPH; Ashley Spahn, BS; Amir A. Toor, MD; Stephanie Waldvogel, BS; Lee M. Greenberger, PhD; Jeffery J. Auletta, MD; Mary M. Horowitz, MD*; Marcie L. Riches, MD; Miguel-Angel Perales, MD

Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals

Delmonte OM, et al.
Journal of Allergy and Clinical Immunology
January 2024
Authors and Affiliates
Ottavia M Delmonte 1, Cihan Oguz 2, Kerry Dobbs 3, Katherine Myint-Hpu 3, Boaz Palterer 3, Michael S Abers 3, Deborah Draper 3, Meng Truong 3, Ian M Kaplan 4, Rachel M Gittelman 4, Yu Zhang 3, Lindsey B Rosen 3, Andrew L Snow 5, Clifton L Dalgard 6, Peter D Burbelo 7, Luisa Imberti 8, Alessandra Sottini 8, Eugenia Quiros-Roldan 9, Francesco Castelli 9, Camillo Rossi 10, Duilio Brugnoni 11, Andrea Biondi 12, Laura Rachele Bettini 12, Mariella D'Angio' 12, Paolo Bonfanti 13, Megan V Anderson 14, Annalisa Saracino 15, Maria Chironna 16, Mariantonietta Di Stefano 17, Jose Ramon Fiore 17, Teresa Santantonio 17, Riccardo Castagnoli 18, Gian Luigi Marseglia 18, Mary Magliocco 19, Marita Bosticardo 3, Francesca Pala 3, Elana Shaw 3, Helen Matthews 19, Sarah E Weber 19, Sandhya Xirasagar 20, Jason Barnett 20, Andrew J Oler 20, Dimana Dimitrova 21, Jenna R E Bergerson 3, David H McDermott 22, V Koneti Rao 3, Philip M Murphy 22, Steven M Holland 3, Andrea Lisco 14, Helen C Su 3, Michail S Lionakis 3, Jeffrey I Cohen 23, Alexandra F Freeman 3, Thomas M Snyder 4, Justin Lack 2, Luigi D Notarangelo 24; 1 Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: ottavia.delmonte@nih.gov. 2 Integrated Data Sciences Section, Research Technology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. 3 Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. 4 Adaptive Biotechnologies, Seattle, WA 98109, USA. 5 Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20892, USA. 6 Department of Anatomy, Physiology & Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD 20815, USA. 7 Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA. 8 Section of Microbiology, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy. 9 Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy. 10 Direzione Sanitaria, ASST Spedali Civili di Brescia, Italy. 11 Laboratorio Analisi Chimico-Cliniche, ASST Spedali Civili, Brescia, Italy. 12 Pediatric Department and Centro Tettamanti-European Reference Network on Paediatric Cancer, European Reference Network on Haematological Diseases, and European Reference Network on Hereditary Metabolic Disorders-University of Milano-Bicocca-Fondazione MBBM, Monza, Italy. 13 Department of Infectious Diseases, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy. 14 Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. 15 Clinic of Infectious Diseases, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, University of Bari, Bari, Italy. 16 Hygiene Section, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, Italy. 17 Department of Medical and Surgical Sciences, Section of Infectious Diseases, University of Foggia, Foggia, Italy. 18 Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. 19 Molecular Development of the Immune System Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD 20892, USA. 20 Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. 21 Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. 22 Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. 23 Laboratory of Infectious Diseases, National Institute of Allergy and Infectious diseases, National Institutes of Health, Bethesda, MD 20892, USA. 24 Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: luigi.notarangelo2@nih.gov.

Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19

Ford ES, et al.
Nature Immunology
December 2023
Authors and Affiliates
Emily S Ford 1,2, Koshlan Mayer-Blackwell 2, Lichen Jing 1, Kerry J Laing 1, Anton M Sholukh 2, Russell St Germain 2, Emily L Bossard 2, Hong Xie 3, Thomas H Pulliam 1, Saumya Jani 1,3, Stacy Selke 3, Carlissa J Burrow 1, Christopher L McClurkan 1, Anna Wald 1,2,3,4, Alexander L Greninger 2,3, Michael R Holbrook 5, Brett Eaton 5, Elizabeth Eudy 5, Michael Murphy 5, Elena Postnikova 5, Harlan S Robins 6, Rebecca Elyanow 6, Rachel M Gittelman 6,7, Matyas Ecsedi 8,9, Elise Wilcox 8, Aude G Chapuis 1,8, Andrew Fiore-Gartland 2, David M Koelle 10,11,12,13,14; 1 Department of Medicine, University of Washington, Seattle, WA, USA. 2 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. 3 Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. 4 Department of Epidemiology, University of Washington, Seattle, WA, USA. 5 Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA. 6 Adaptive Biotechnologies, Seattle, WA, USA. 7 Guardant Health, Redwood City, CA, USA. 8 Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. 9 Takeda Oncology, Cambridge, MA, USA. 10 Department of Medicine, University of Washington, Seattle, WA, USA. 11 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. 12 Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. 13 Department of Global Health, University of Washington, Seattle, WA, USA. 14 Department of Translational Research, Benaroya Research Institute, Seattle, WA, USA. dkoelle@medicine.washington.edu.

SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients

Onyango TB, et al.
Frontiers in Immunology
December 2023
Authors and Affiliates
Therese Bredholt Onyango 1, Fan Zhou 1, Geir Bredholt 2, Karl A Brokstad 1,3, Sarah Lartey 1, Kristin G-I Mohn 1,4, Türküler Özgümüs 5, Bård Reiakvam Kittang 6, Dagrun Waag Linchausen 7, Shahin Shafiani 8, Rebecca Elyanow 8, Bjørn Blomberg 2,4,9, Nina Langeland 2,4,9, Rebecca Jane Cox 1,10; Bergen COVID-19 Research Group; 1 Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway. 2 Department of Clinical Science, University of Bergen, Bergen, Norway. 3 Department of Safety, Chemistry and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Bergen, Norway. 4 Department of Medicine, Haukeland University Hospital, Bergen, Norway. 5 Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. 6 Department of Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway. 7 Bergen Municipality Emergency Clinic, Bergen, Norway. 8 Adaptive Biotechnologies, Seattle, WA, United States. 9 National Advisory Unit for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway. 10 Department of Microbiology, Haukeland University Hospital, Bergen, Norway.

Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells

Keitany GJ, et al.
Cell Chemical Biology
December 2023
Authors and Affiliates
Gladys J Keitany 1, Benjamin E R Rubin 1, Meghan E Garrett 1, Andrea Musa 1, Jeff Tracy 1, Yu Liang 1, Peter Ebert 1, Amanda J Moore 1, Jonathan Guan 1, Erica Eggers 1, Ninnia Lescano 1, Ryan Brown 1, Adria Carbo 1, Hussein Al-Asadi 1, Travers Ching 1, Austin Day 1, Rebecca Harris 1, Charles Linkem 1, Dimitry Popov 1, Courtney Wilkins 1, Lianqu Li 2, Jiao Wang 2, Chuanxin Liu 2, Li Chen 2, Jennifer N Dines 1, Caroline Atyeo 3, Galit Alter 3, Lance Baldo 1, Anna Sherwood 1, Bryan Howie 1, Mark Klinger 1, Erik Yusko 1, Harlan S Robins 1, Sharon Benzeno 1, Amy E Gilbert 4; 1 Adaptive Biotechnologies, Seattle, WA 98109, USA. 2 GenScript ProBio Biotech, Nanjing, Jiangsu Province, China. 3 Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA. 4 Adaptive Biotechnologies, Seattle, WA 98109, USA. Electronic address: agilbert@adaptivebiotech.com.
Previous Next